- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05342337
Exercise Therapy With Telerehabilitation in Patients Living With HIV
Investigation of the Effectiveness of Biopsychosocial Exercise Therapy Approach With Telerehabilitation in Patients Living With HIV
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
55 individuals living with HIV (PLWH) were included in the study. Among those individuals, 25 individuals who volunteer to exercise with telerehabilitation will be grouped in the telerehabilitation group. The rest of the individuals who do not participate in the exercise group will be in the control group.
Group 1: Telerehabilitation group: Individuals in the telerehabilitation group attend sessions that last for one and a half hours, 3 days a week for 12 weeks, in the company of an investigator over the videoconference through zoom. The investigator, who provides supervision during the sessions, also participates in the exercises simultaneously.
Group 2: Control group: Individuals in the control group continue their routine drugs.
Both the telerehabilitation exercise group and the control group continue their drug treatments during the 12 weeks of the period.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Aysenur Tuncer, PhD
- Phone Number: +90 342 211 80 80
- Email: aysenur.tuncer@hku.edu.tr
Study Contact Backup
- Name: Erkin O Sari, MSc
- Email: eoguz.sari@hku.edu.tr
Study Locations
-
-
-
Gaziantep, Turkey
- Hasan Kalyoncu University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients living with HIV (PLWH),
- Ages between 18 and 65 years old,
- Participants attend and follow instructions through telerehabilitation.
Exclusion Criteria:
- Participants who use recreational drugs
- Participants who do not adapt to the exercises through telerehabilitation,
- Participants who did not agree to be volunteers are not included in our study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Telerehabilitation Group
The Telerehabilitation program includes a Biopsychosocial Exercise Therapy (BETY) approach. BETY approach includes patient education on pain, functional body stabilization exercises (mind-body information management), dance therapy authentic movement (emotion-state information management), and sexual information management. |
The Telerehabilitation program includes a Biopsychosocial Exercise Therapy (BETY) approach. BETY approach includes patient education on pain, functional body stabilization exercises (mind-body information management), dance therapy authentic movement (emotion-state information management), and sexual information management. Telerehabilitation group participate in the sessions that last for one and a half hours, 3 days a week for 12 weeks, video conference over the Zoom program. The investigator, who provides supervision during the sessions, also participates in the exercises simultaneously. |
Active Comparator: Control Group
The control group participants include those who do not want to receive exercise treatment with telerehabilitation and take their routine medications during the 12 weeks period.
|
The control group participants include those who do not want to receive exercise treatment with telerehabilitation and take their routine medications during the 12 weeks period.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from Baseline in Biopsychosocial Exercise Therapy Questionnaire (BETY-BQ) at 12 weeks
Time Frame: Baseline, 12 weeks
|
The Biopsychosocial Exercise Therapy Questionnaire (BETY-BQ), consists of 30 questions.
Each of the items on the scale is scored between 0-and 4 in accordance with the Likert system.
A higher score indicates a poor biopsychosocial status (4: Yes always, 3: Yes often, 2: Yes sometimes, 1: Yes rarely, 0: No, never).
|
Baseline, 12 weeks
|
Change from Baseline in Short Form-36 (SF-36) at 12 weeks
Time Frame: Baseline, 12 weeks
|
The Short Form-36 (SF-36) scale, is the most commonly used quality of life scale that evaluate physical and mental health.
İt consists of 8 subscales.
These subscales, physical function, physical orientation role restriction, pain, general health, vitalization, social function, emotional role restrictiveness, and mental health.
Points range from 0-to 100 and the best health status of 100 points shows the worst health status of 0 points.
|
Baseline, 12 weeks
|
Change from Baseline in Hospital Anxiety and Depression Scale (HADS) at 12 weeks
Time Frame: Baseline, 12 weeks
|
The HADS is a self-rating scale.
It contains two subscales measuring symptoms of depression (HADS-D) and anxiety (HADS-A) during the previous week.
It includes seven statements on each disorder, and each response consists of a four-point rating scale (0 to 3); a higher score depicts a worse condition.
For each subscale, the total score is at most 21.
A score of ≥11 is considered a clinically significant disorder, whereas a score between 8 and 10 suggests a mild disorder.
|
Baseline, 12 weeks
|
Change from Baseline in FRAIL scale at 12 weeks
Time Frame: Baseline, 12 weeks
|
The FRAIL scale is a clinical frailty screening tool.
It consists of five components: Fatigue, resistance, ambulation, illness, and loss of weight (score range 0-5), and evaluates the status and severity of frailty.
The presence of ≥3 components in a participants is considered frailty, while the presence of more components indicates more serious vulnerability.
|
Baseline, 12 weeks
|
Change from Baseline in Clinical Frailty Scale (CFS) scale at 12 weeks
Time Frame: Baseline, 12 weeks
|
The Clinical Frailty Scale is an inclusive 9-point scale to summarize the overall level of fitness or frailty of participants.
The scale can be easily applied to the participants.
İt is based on a subjective clinical assessment categorized by the investigators.
A clinical fragile scale score greater than four is to be fragility and clinical indicator.
Higher scores mean greater risk.
|
Baseline, 12 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Aysenur Tuncer, PhD, Hasan Kalyoncu University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- RNA Virus Infections
- Virus Diseases
- Infections
- Blood-Borne Infections
- Communicable Diseases
- Sexually Transmitted Diseases, Viral
- Sexually Transmitted Diseases
- Lentivirus Infections
- Retroviridae Infections
- Immunologic Deficiency Syndromes
- Immune System Diseases
- Urogenital Diseases
- Genital Diseases
- HIV Infections
Other Study ID Numbers
- 2022/024
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV Infections
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
University of California, San DiegoUniversity of California, Los Angeles; University of Southern California; California... and other collaboratorsCompleted
-
Gérond'ifRecruiting
-
University of California, DavisCompleted
-
University of California, San DiegoNational Center for Complementary and Integrative Health (NCCIH)CompletedHIV PositiveUnited States
-
University of ChicagoUniversity of Athens; National Development and Research Institutes, Inc.Completed
-
HIV Prevention Trials NetworkNational Institute on Drug Abuse (NIDA); National Institute of Allergy and...CompletedHIV PositiveIndonesia, Ukraine, Vietnam
-
University of ZimbabweCompleted
-
Florida International UniversityCompleted
-
Boston Children's HospitalNational Institute on Minority Health and Health Disparities (NIMHD)Completed
Clinical Trials on Telerehabilitation Group
-
Marmara UniversityEnrolling by invitationHemiparetic Cerebral PalsyTurkey
-
Bright Cloud International CorpNational Cancer Institute (NCI); Rutgers, The State University of New JerseyRecruitingCognitive Impairment, MildUnited States
-
University of Eastern FinlandOulu University Hospital; Kuopio University HospitalNot yet recruitingCoronary Artery Disease
-
Muğla Sıtkı Koçman UniversityCompleted
-
Gazi UniversityCumhuriyet UniversityRecruiting
-
Universidad de GranadaCarlos III Health InstituteCompleted
-
Necmettin Erbakan UniversityNot yet recruitingCoronary Artery Disease | Cardiac Disease
-
Bahçeşehir UniversityCompleted
-
Hasan Kalyoncu UniversityCompletedBruxism | Myofascial Pain | Temporomandibular DisorderTurkey